VS-H101

N/A

Report date: 2025/03/17 11:01:30
NME

Base Information

Drug NameVS-H101
Drug Alias NameVS-H101VSH101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolo like kinase 1 modulators
TargetsPolo like kinase 1
Therapy Area/IndicationsVenous Thromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesFosun Wanbang (Jiangsu) Pharmaceutical Group Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesFosun Wanbang (Jiangsu) Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsVenous Thromboembolism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A